Stocks
Sabra Health Care Financial Statements (SBRA) |
||||||||||
| Sabra Health Caresmart-lab.ru | % | 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 22.02.2021 | 22.02.2022 | 31.12.2022 | 21.02.2023 | 27.02.2024 | 27.02.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 598.6 | 569.5 | 624.8 | 624.8 | 655.8 | 648.5 | |||
| Operating Income, bln rub | 241.2 | 19.0 | 234.7 | 135.6 | 235.1 | 326.4 | ||||
| EBITDA, bln rub | ? | 418.0 | 198.0 | 216.9 | 323.4 | 418.2 | 420.7 | |||
| Net profit, bln rub | ? | 138.4 | -113.3 | -77.6 | -77.6 | 13.8 | 13.8 | |||
| OCF, bln rub | ? | 354.9 | 356.4 | 315.7 | 315.7 | 301.1 | 300.6 | |||
| CAPEX, bln rub | ? | 105.6 | 33.6 | 0.000 | 0.000 | 5.24 | 107.2 | |||
| FCF, bln rub | ? | 249.3 | 322.8 | 315.7 | 315.7 | 306.4 | 203.9 | |||
| Dividend payout, bln rub | 278.3 | 262.9 | 277.2 | 277.2 | 277.4 | 277.4 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 201.1% | 0.00% | 0.00% | 0.00% | 2 017% | 2 017% | ||||
| OPEX, bln rub | 211.3 | 217.6 | 227.5 | 227.5 | 42.4 | 173.2 | ||||
| Cost of production, bln rub | 131.6 | 141.2 | 162.6 | 162.6 | 378.3 | 238.1 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 100.4 | 98.6 | 105.5 | 105.5 | 134.4 | 128.6 | ||||
| Assets, bln rub | 5 986 | 5 967 | 5 748 | 5 748 | 5 386 | 5 386 | ||||
| Net Assets, bln rub | ? | 3 409 | 3 380 | 3 056 | 3 056 | 2 803 | 2 803 | |||
| Debt, bln rub | 2 372 | 2 394 | 2 507 | 2 704 | 2 447 | 2 447 | ||||
| Cash, bln rub | 59.1 | 112.0 | 49.3 | 49.3 | 46.7 | 46.7 | ||||
| Net debt, bln rub | 2 313 | 2 282 | 2 457 | 2 654 | 2 400 | 2 400 | ||||
| Ordinary share price, rub | 17.4 | 13.5 | 12.4 | 12.4 | 14.3 | 14.2 | ||||
| Number of ordinary shares, mln | 206.2 | 219.1 | 230.9 | 230.9 | 231.2 | 231.2 | ||||
| Market cap, bln rub | 3 582 | 2 966 | 2 871 | 2 871 | 3 299 | 3 290 | ||||
| EV, bln rub | ? | 5 895 | 5 249 | 5 328 | 5 525 | 5 699 | 5 690 | |||
| Book value, bln rub | 3 326 | 3 325 | 3 016 | 3 016 | 2 772 | 2 772 | ||||
| EPS, rub | ? | 0.67 | -0.52 | -0.34 | -0.34 | 0.06 | 0.06 | |||
| FCF/share, rub | 1.21 | 1.47 | 1.37 | 1.37 | 1.33 | 0.88 | ||||
| BV/share, rub | 16.1 | 15.2 | 13.1 | 13.1 | 12.0 | 12.0 | ||||
| EBITDA margin, % | ? | 69.8% | 34.8% | 34.7% | 51.8% | 63.8% | 64.9% | |||
| Net margin, % | ? | 23.1% | -19.9% | -12.4% | -12.4% | 2.10% | 2.12% | |||
| FCF yield, % | ? | 6.96% | 10.9% | 11.0% | 11.0% | 9.29% | 6.20% | |||
| ROE, % | ? | 4.06% | -3.35% | -2.54% | -2.54% | 0.49% | 0.49% | |||
| ROA, % | ? | 2.31% | -1.90% | -1.35% | -1.35% | 0.26% | 0.26% | |||
| P/E | ? | 25.9 | -26.2 | -37.0 | -37.0 | 239.8 | 239.2 | |||
| P/FCF | 14.4 | 9.19 | 9.09 | 9.09 | 10.8 | 16.1 | ||||
| P/S | ? | 5.98 | 5.21 | 4.59 | 4.59 | 5.03 | 5.07 | |||
| P/BV | ? | 1.08 | 0.89 | 0.95 | 0.95 | 1.19 | 1.19 | |||
| EV/EBITDA | ? | 14.1 | 26.5 | 24.6 | 17.1 | 13.6 | 13.5 | |||
| Debt/EBITDA | 5.53 | 11.5 | 11.3 | 8.21 | 5.74 | 5.71 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0 | ||||||
| CAPEX/Revenue, % | 17.6% | 5.90% | 0.00% | 0.00% | 0.80% | 16.5% | ||||
| Sabra Health Care shareholders | ||||||||||
